David Tierney

David S.
Tierney was the founder of Oceana Therapeutics, Inc. (founded in 2008) and held the title of President, Chief Operating Officer & Director in 2011.
He is currently the President, CEO, Secretary, Treasurer & Director at Aramis Biosciences, Inc., an Independent Director at Catalyst Pharmaceuticals, Inc. since 2002, and a Director at Bimeda, Inc. since 2018.
Dr. Tierney has previously held positions as the President, Chief Executive Officer & Director at Valera Pharmaceuticals, Inc. from 2000 to 2007, President & Chief Executive Officer at Icon Bioscience, Inc. from 2014 to 2018, Chief Executive Officer at Pharma Two B Ltd. in 2020, President & Chief Executive Officer at BioPharmX Corp.
from 2019 to 2020, and Senior Vice President-Drug Development at Roberts Pharmaceutical Corp.
from 1997 to 2000.
He has also served as a Director at Bioject Medical Technologies, Inc., Able Laboratories, Inc., Apricus Biosciences, Inc., Elan Pharmaceuticals LLC, Viatar CTC Solutions, Inc., Palvella Therapeutics, Inc., and Zevra Therapeutics, Inc. Additionally, Dr. Tierney was a Venture Partner at Signet Healthcare Partners LLC in 2013 and President of Biovail Technologies Ltd. in 2000.
Dr. Tierney obtained his doctorate degree from the Royal College of Surgeons in 1987.